Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Ocellaris Pharma, Inc.
TScan Therapeutics, Inc.
AVM Biotechnology Inc
Bicara Therapeutics
Leap Therapeutics, Inc.
Numab Therapeutics AG
Revolution Medicines, Inc.
Carisma Therapeutics Inc
Advaxis, Inc.
Pfizer
Revolution Medicines, Inc.
Fate Therapeutics
Revolution Medicines, Inc.
SpeciCare